Syneos Health, the fully integrated biopharmaceutical solutions organization, introduced FSP 360, an evolved FSP model that provides access to the industry’s to a broad range of traditional and non-traditional FSP capabilities.
“As customers look to consolidate outsourced clinical solutions, traditional static FSP models no longer meet their unique scientific and operational demands,” said Paul Colvin, President, Syneos Health Clinical Solutions.
With our evolved model, engagements can be scaled based on where a customer is in their outsourcing evolution. Ranging from accessing functional excellence to quickly meet specific project-based needs, to a multifunction FSP providing a combination of capabilities across an entire portfolio, FSP 360 achieves speed, quality and efficiencies.
This model is a hybrid solution that stands alone or in combination with full-service outsourcing. When combined with Syneos Health’s best-in-class Commercial Solutions, including consulting, regulatory and market access capabilities, we can further optimize customer outcomes.
An essential part of our Biopharmaceutical Acceleration Model™ (BAM), this comprehensive clinical continuum delivers what today’s customers need most — an end-to-end clinical partner committed to strategic solutions designed to accelerate performance.
Unrivaled scale and experience – wherever you need it
Syneos Health has more than two decades of FSP experience and expertise. This foundation fuels innovation to deliver new models while realizing efficiencies — leveraging thousands of lessons learned.
